Morgan Stanley reiterates Axon Enterprise stock rating on growth outlook

Morgan Stanley reiterated an Overweight on Axon with a $675 price target while TD Cowen raised its PT to $950 after reporting 53% Q4 bookings growth and fiscal 2026 revenue guidance of 27%-30% (Street 25.5%). Axon shares are down 49% over six months, trading at $372.87 near a 52-week low of $362.73; the company reported ~33% LTM revenue growth and ~60% gross margins. Analysts largely remain positive on growth and AI monetization (MS cites a $159bn TAM), though InvestingPro flags the stock as overvalued and BofA trimmed its PT to $700 despite maintaining a Buy.

Analysis

Axon’s structural advantage—owning both endpoint hardware and a growing software/AI stack—creates utility-style recurring revenue optionality but also concentration risk: execution hinges on converting hardware customers into high-margin software subscribers at scale. That conversion path tends to generate step-function margin improvement only after multi-year penetration thresholds are crossed; expect a lumpy, booking-driven P&L cadence rather than smooth quarterly linearity.

Second-order winners from a successful roll-out are non-obvious: cloud infra and inference-accelerator vendors benefit from higher per-customer compute spend, and specialist drone and sensor component suppliers will see demand as Axon pushes into aerial solutions; conversely, pure-play video storage and legacy hardware vendors face erosion as software subscription economics internalize services. Supply-chain constraints for specialized camera modules, RF links, and FAA-like certification cycles for drones could create timing risks even if end demand remains intact.

Key near-term catalysts are bookings and cadence of enterprise (public-sector) renewals, while medium-term proof points are per-customer ARPU uplift and gross margin expansion as software mix rises; regulatory or legal shocks tied to evidence handling, privacy, or algorithmic decision-making are asymmetric downside events that can compress multiples quickly. Sector multiple compression or a broader AI funding re-rate is the plausible macro path to a meaningful drawdown even if company fundamentals remain intact, so hedge sizing and time horizon selection matter.

The consensus framing assumes smooth monetization of AI tailwinds; the contrarian view is that inference cost inflation, slow procurement cycles in government customers, and integration friction could delay visible margin upside by 12–36 months while keeping headline growth noisy. That makes a staged exposure with defined downside protection more attractive than an unhedged long into the next few quarters of earnings and guidance volatility.

Key Decisions for Investors

• Initiate a 0.5–1.0% portfolio long in AXON via a 12–18 month call spread (buy LEAP call ~30% OTM, sell a higher strike ~60% OTM) to capture multi-quarter proof points while capping premium outlay. Target: asymmetric 2–3x upside to premium if market re-rates on sustainable ARPU uplift; max loss = premium paid. Timeframe: 12–18 months.
• Pair trade to isolate idiosyncratic execution: go long AXON (50% notional) and short a broad software ETF (IGV) for an equalized beta hedge (50% notional). Objective: capture company-specific rerating if AI monetization shows real ARPU/margin progress while neutralizing sector multiple moves. Timeframe: 6–12 months; unwind on >30% divergence or on confirmed multi-quarter ARPU acceleration.
• Event/volatility play into next earnings: buy a directional calendar (long 3–6 month calls, sell near-term calls) around expected booking cadence to monetize a positive surprise while financing cost; keep position size <0.5% portfolio. Risk: earnings miss leads to rapid time decay—use a stop if implied vol rises sharply or stock gap down >20%.
• Tactical supply-chain exposure: accumulate small exposure (0.25–0.5% each) to cloud-infrastructure/accelerator names (e.g., AMZN, NVDA) and select drone/sensor suppliers that are domestic-capable to profit from downstream deployment if Axon scales hardware-associated AI services. Timeframe: 12–36 months; thesis fails if AI inference costs remain structurally high or procurement stalls.